Where others have failed will Atl1102 succeed ?, page-819

First 819 Last

Share
Profile

Follow
raisinsareheresy

253 Posts.

103

17/10/21

23:24

Post #: 56864151
Share

Originally posted by samfiodiving: ↑

Thanks Shyaam
We have been informed if we can replicate the 6 month study results over our 12 month ph2b that we are about to start then because of the rare disease and no other treatment out there then we will go to market

Of course there may well be follow up studies as we have been informed once the trial is ended then the treatment will be allowed to continue for an extended period

I am not sure how the ambulant boys are going to introduced we will hopefully find this out tomorrow

Also with regard to the FDA once more i have gone over this but by the time they have organised monkey trials etc etc i would be tempted to hold of on the FDA route and go to the FDA once the trial is completed along with the advocacy groups and try to get our drug to market through the FDA on the back of what will hopefully be a successful Ph2b and market approval through the EMA therefore reducing costs and having a global drug @ market across all continents through the one EMA trial

Any way that is a while of see what the immediate future holds first up

SEE HOW WE GO

Expand

That’s incredible news!

I also understand that we can start immediate phase 2 trials for our other indications with ATL1102, is that right? (Predicated on our existing Pre clin/phase 1 safety data)

If so, would we need to do Phase 2, Phase 2B and Phase 3 trials for these other indications, or is it a shorter process?

ANP Price at posting: 29.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

There are more pages in this discussion • 278 more messages in this thread...

First 819 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.9¢		Change -0.002(2.47%)		Mkt cap ! $81.90M

Open	High	Low	Value	Volume
8.0¢	8.0¢	7.9¢	$230.1K	2.904M

Buyers (Bids)

No.	Vol.	Price($)
1	51000	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	163520	2

View Market Depth

No.	Vol.	Price($)
1	51000	0.079
18	1244001	0.078
10	1037506	0.077
9	894271	0.076
10	1100649	0.075

Price($)	Vol.	No.
0.080	163520	2
0.081	344626	2
0.082	150000	1
0.083	368750	3
0.084	200000	1

Last trade - 15.57pm 01/11/2024 (20 minute delay)

PER (ASX) Chart

Where others have failed will Atl1102 succeed ?, page-819

Top Stories

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Buyers (Bids)

Sellers (Offers)